Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system

Neurobiology of Disease
Jing ZhangMichael Chopp

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). No effective remyelination therapies are in use. We hypothesized that thymosin beta4 (Tβ4) is an effective remyelination treatment by promoting differentiation of oligodendrocyte progenitor cells (OPCs), and that the epidermal growth factor receptor (EGFR) signaling pathway contributes to this process. Two demyelination animal models were employed in this study: 1) experimental autoimmune encephalomyelitis (EAE), an animal model of MS. EAE mice were treated daily for 30days, with Tβ4 or saline treatment initiated on the day of EAE onset; and 2) cuprizone diet model, a non-inflammatory demyelination model. The mice were treated daily for 4weeks with Tβ4 or saline after fed a cuprizone diet for 5weeks. Immunofluorescent staining and Western blot were performed to measure the differentiation of OPCs, myelin and axons, respectively. To obtain insight into mechanisms of action, the expression and activation of the EGFR pathway was measured. AG1478, an EGFR inhibitor, was employed in a loss-of-function study. Data revealed that animals in both demyelination models exhibited significant reduction of myelin basic protein (MBP(+)) levels and CNPase(+...Continue Reading

References

Feb 15, 2002·Brain : a Journal of Neurology·Guus Wolswijk
Jan 18, 2003·Progress in Neurobiology·Martin Stangel, Hans-Peter Hartung
Mar 5, 2003·Brain : a Journal of Neurology·Christian ConfavreuxPatrice Adeleine
Jan 6, 2005·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Elisa A Waxman, David R Lynch
Dec 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adan AguirreVittorio Gallo
May 15, 2007·Annals of the New York Academy of Sciences·Nicola SmartPaul R Riley
Jun 5, 2007·Nature Protocols·Ying ChenQ Richard Lu
Jun 30, 2007·Annals of the New York Academy of Sciences·Deepak SrivastavaIldiko Bock-Marquette
Jun 30, 2007·Annals of the New York Academy of Sciences·Mahnaz BadamchianAllan L Goldstein
Jul 10, 2007·Nature Neuroscience·Adan AguirreVittorio Gallo
Jul 17, 2007·Angiogenesis·Nicola SmartPaul R Riley
Oct 20, 2007·Annals of the New York Academy of Sciences·David Crockford
Jul 23, 2008·Journal of Neurochemistry·Dana M McTigue, Richa B Tripathi
Aug 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rina AharoniRuth Arnon
Sep 2, 2008·Stem Cell Reviews·Raniero L PeruQ Richard Lu
Oct 22, 2008·Nature Reviews. Neuroscience·Robin J M Franklin, Charles Ffrench-Constant
Mar 28, 2009·Journal of Neurology·Martin Stangel
Apr 22, 2011·Brain : a Journal of Neurology·Mark R KotterHans-Peter Hartung
May 5, 2011·FEBS Letters·Jigisha R Patel, Robyn S Klein
Mar 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Leiliane P SousaJoseph Schlessinger
Jul 3, 2015·Expert Opinion on Emerging Drugs·Michael Chopp, Zheng Gang Zhang

❮ Previous
Next ❯

Citations

Nov 10, 2016·Behavioural Brain Research·Hajime TakaseJosephine Lok
Mar 10, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Elena GiacominiMartina Severa
Jul 8, 2019·Neurological Research and Practice·Peter GöttleDavid Kremer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.